Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Dyne Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 118
- −9 vs. Q1 2023
- Shares held
- 59.2M
- +4.56M (+8.4%) vs. Q1 2023
- Total value
- $665.9M
- +$37.1M (+5.9%) vs. Q1 2023
- New holders
- 15
- 57 more added
- Sold out
- 24
- 28 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $4.23B |
| Q1 2026 | 228 | $3.40B |
| Q4 2025 | 233 | $3.48B |
| Q3 2025 | 207 | $1.97B |
| Q2 2025 | 198 | $1.22B |
| Q1 2025 | 205 | $1.29B |
| Q4 2024 | 200 | $2.63B |
| Q3 2024 | 200 | $4.03B |
| Q2 2024 | 193 | $3.92B |
| Q1 2024 | 169 | $2.71B |
| Q4 2023 | 124 | $930.0M |
| Q3 2023 | 114 | $536.6M |
| Q2 2023 | 118 | $665.9M |
| Q1 2023 | 127 | $628.7M |
| Q4 2022 | 113 | $576.2M |
| Q3 2022 | 102 | $565.8M |
| Q2 2022 | 90 | $320.7M |
| Q1 2022 | 94 | $456.6M |
| Q4 2021 | 93 | $568.3M |
| Q3 2021 | 83 | $572.8M |
| Q2 2021 | 76 | $753.4M |
| Q1 2021 | 75 | $533.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 815,085 | $9.17M | 0.29% | +282,476+53.0% | Added |
| FMR LLC | 899,292 | $10.1M | 0.00% | +490,236+119.8% | Added |
| Armistice Capital, LLC | 912,000 | $10.3M | 0.26% | +912,000 | New |
| Braidwell LP | 1,377,872 | $15.5M | 0.51% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,650,150 | $18.6M | 3.04% | 00.0% | Unchanged |
| State Street Corp | 1,779,740 | $20.0M | 0.00% | +1,178,928+196.2% | Added |
| Logos Global Management LP | 1,780,000 | $20.0M | 2.77% | +80,000+4.7% | Added |
| Franklin Resources Inc | 1,913,479 | $21.5M | 0.01% | +21,120+1.1% | Added |
| Goldman Sachs Group Inc | 2,009,529 | $22.6M | 0.01% | +515,079+34.5% | Added |
| VR Adviser, LLC | 2,173,913 | $24.5M | 3.91% | +2,173,913 | New |
| Vida Ventures Advisors, LLC | 2,220,034 | $25.0M | 32.61% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 2,259,535 | $25.4M | 0.15% | −667,743−22.8% | Reduced |
| Vanguard Group Inc | 2,388,741 | $26.9M | 0.00% | +941,984+65.1% | Added |
| Deep Track Capital, LP | 2,499,912 | $28.1M | 1.31% | +165,279+7.1% | Added |
| Citadel Advisors LLC | 2,706,003 | $30.4M | 0.03% | −322,797−10.7% | Reduced |
| BlackRock Inc. | 3,322,187 | $37.4M | 0.00% | +702,966+26.8% | Added |
| MPM Asset Management LLC | 4,951,303 | $55.7M | 27.32% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 9,885,449 | $111.2M | 13.84% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −478,401−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −190,363−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −107,252−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −102,431−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −73,300−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −61,003−100.0% | Sold out |
| CWM Advisors, LLC | 0 | $0 | 0.00% | −39,722−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −38,532−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −37,501−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,629−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −27,240−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −24,064−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −23,668−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −21,010−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −20,900−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −17,726−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,183−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,629−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −10,441−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −10,400−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,559−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −741−100.0% | Sold out |